Yvan Vandenplas

1.4k total citations
22 papers, 813 citations indexed

About

Yvan Vandenplas is a scholar working on Gastroenterology, Surgery and Endocrine and Autonomic Systems. According to data from OpenAlex, Yvan Vandenplas has authored 22 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Gastroenterology, 11 papers in Surgery and 3 papers in Endocrine and Autonomic Systems. Recurrent topics in Yvan Vandenplas's work include Gastroesophageal reflux and treatments (15 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Congenital Diaphragmatic Hernia Studies (3 papers). Yvan Vandenplas is often cited by papers focused on Gastroesophageal reflux and treatments (15 papers), Helicobacter pylori-related gastroenterology studies (5 papers) and Congenital Diaphragmatic Hernia Studies (3 papers). Yvan Vandenplas collaborates with scholars based in Belgium, Netherlands and France. Yvan Vandenplas's co-authors include Harry Goyvaerts, Rudy Helven, Liliane Sacré, Bruno Hauser, Frédèric Gottrand, Marc A. Benninga, Uwe Blecker, Clara M. Loots, Tobias G. Wenzl and Silvia Salvatore and has published in prestigious journals such as Gastroenterology, PEDIATRICS and Clinical Nutrition.

In The Last Decade

Yvan Vandenplas

22 papers receiving 765 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yvan Vandenplas Belgium 12 606 564 158 77 73 22 813
A. Craig Hillemeier United States 12 333 0.5× 410 0.7× 99 0.6× 49 0.6× 42 0.6× 24 655
Michael S. Halata United States 13 210 0.3× 239 0.4× 78 0.5× 17 0.2× 28 0.4× 25 395
Federico Moser Argentina 15 216 0.4× 634 1.1× 251 1.6× 54 0.7× 56 0.8× 33 736
David H. Balaban United States 7 589 1.0× 605 1.1× 183 1.2× 176 2.3× 10 0.1× 13 770
Stephanie Fitzgerald United States 10 500 0.8× 632 1.1× 163 1.0× 18 0.2× 21 0.3× 15 810
Thomas P. Hüttl Germany 18 104 0.2× 586 1.0× 267 1.7× 59 0.8× 51 0.7× 55 757
Renato A. Luna Brazil 9 239 0.4× 299 0.5× 200 1.3× 8 0.1× 63 0.9× 19 588
Maritza Proano United States 6 482 0.8× 347 0.6× 31 0.2× 8 0.1× 37 0.5× 6 643
P. J. Treacy Australia 11 234 0.4× 374 0.7× 113 0.7× 53 0.7× 7 0.1× 22 509
Massimiliano Cipriano Italy 11 180 0.3× 701 1.2× 108 0.7× 39 0.5× 103 1.4× 13 789

Countries citing papers authored by Yvan Vandenplas

Since Specialization
Citations

This map shows the geographic impact of Yvan Vandenplas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yvan Vandenplas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yvan Vandenplas more than expected).

Fields of papers citing papers by Yvan Vandenplas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yvan Vandenplas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yvan Vandenplas. The network helps show where Yvan Vandenplas may publish in the future.

Co-authorship network of co-authors of Yvan Vandenplas

This figure shows the co-authorship network connecting the top 25 collaborators of Yvan Vandenplas. A scholar is included among the top collaborators of Yvan Vandenplas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yvan Vandenplas. Yvan Vandenplas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Huysentruyt, Koen, et al.. (2025). Why think twice before prescribing proton pump inhibitors. European Journal of Pediatrics. 184(3). 227–227. 2 indexed citations
3.
Huysentruyt, Koen, et al.. (2024). A synbiotic mixture for the management of infantile colic: A randomized trial. European Journal of Pediatrics. 184(1). 27–27. 1 indexed citations
4.
Huysentruyt, Koen, et al.. (2024). An update on the use of ‘biotics’ in pediatric infectious gastroenteritis. Expert Opinion on Pharmacotherapy. 25(11). 1483–1496. 1 indexed citations
5.
Wenzl, Tobias G., et al.. (2012). Indications, Methodology, and Interpretation of Combined Esophageal Impedance‐pH Monitoring in Children. Journal of Pediatric Gastroenterology and Nutrition. 55(2). 230–234. 108 indexed citations
6.
Blumer, Jeffrey L., Melvin B. Heyman, Yvan Vandenplas, & Robert M. Ward. (2003). What Safety Data Are Needed for a Medication to Treat Gastroesophageal Reflux in Premature Infants? In Children Younger Than 1 Year of Age? How to Design a Long-Term Safety Registry for Children?. Journal of Pediatric Gastroenterology and Nutrition. 37(Supplement 1). S69–S71. 1 indexed citations
7.
Cools, Filip, Avram Benatar, Adel Bougatef, & Yvan Vandenplas. (2001). The Effect of Cisapride on the Corrected QT Interval and QT Dispersion in Premature Infants. Journal of Pediatric Gastroenterology and Nutrition. 33(2). 178–181. 2 indexed citations
8.
Vandenplas, Yvan. (2000). Current Pediatric Indications for Cisapride. Journal of Pediatric Gastroenterology and Nutrition. 31(5). 480–489. 15 indexed citations
9.
Vandenplas, Yvan & Bruno Hauser. (2000). Gastro-oesophageal reflux, sleep pattern, apparent life threatening event and sudden infant death. The point of view of a gastro-enterologist. European Journal of Pediatrics. 159(10). 726–729. 25 indexed citations
10.
Vandenplas, Yvan. (1999). Diagnosis and Treatment of Gastroesophageal Reflux Disease in Infants and Children. Canadian Journal of Gastroenterology and Hepatology. 14(D). 26D–34D. 5 indexed citations
11.
Vandenplas, Yvan, Dominique C. Belli, Avram Benatar, et al.. (1999). The Role of Cisapride in the Treatment of Pediatric Gastroesophageal Reflux. Journal of Pediatric Gastroenterology and Nutrition. 28(5). 518–528. 72 indexed citations
12.
Vandenplas, Yvan, Dominique C. Belli, S. Cadranel, et al.. (1997). A critical appraisal of current management practices for infant regurgitation - recommendations of a working party. European Journal of Pediatrics. 156(5). 343–357. 79 indexed citations
13.
Vandenplas, Yvan, Dominique C. Belli, S. Cadranel, et al.. (1996). Current concepts and issues in the management of regurgitation of infants: a reappraisal. Acta Paediatrica. 85(5). 531–534. 56 indexed citations
14.
Blecker, Uwe, et al.. (1996). The role of "occult" gastroesophageal reflux in chronic pulmonary disease in children.. PubMed. 58(5-6). 348–52. 18 indexed citations
15.
Vandenplas, Yvan, et al.. (1994). Corps étrangers du tractus gastrointestinal supérieur. Acta Endoscopica. 24(4). 363–369. 14 indexed citations
16.
Vandenplas, Yvan, et al.. (1994). A clinical trial with an “anti-regurgitation” formula. European Journal of Pediatrics. 153(6). 419–423. 67 indexed citations
17.
Vandenplas, Yvan, et al.. (1994). Abbreviated oesophageal pH monitoring in infants. European Journal of Pediatrics. 153(2). 80–83. 8 indexed citations
18.
Blecker, Uwe, Bruno Hauser, Sophie Lanciers, et al.. (1993). The Prevalence of Helicobacter pylori-Positive Serology in Asymptomatic Children. Journal of Pediatric Gastroenterology and Nutrition. 16(3). 252–256. 85 indexed citations
19.
Vandenplas, Yvan, Harry Goyvaerts, Rudy Helven, & Liliane Sacré. (1991). Gastroesophageal Reflux, as Measured By 24-Hour pH Monitoring, in 509 Healthy Infants Screened for Risk of Sudden Infant Death Syndrome. PEDIATRICS. 88(4). 834–840. 237 indexed citations
20.
Vandenplas, Yvan, et al.. (1989). Area Under pH 4. Journal of Pediatric Gastroenterology and Nutrition. 9(1). 34–39. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026